TG-C

tissueGene-C · Kolon TissueGene, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TG-C, covering 2016-02-15 to 2026-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee [Phase 3]

See pricing